| 2019-02 | Understanding HLA associations from SNP summary association statistics | 배상철 |
| 2017-01 | Update on the genetic architecture of rheumatoid arthritis | 배상철 |
| 2018-04 | Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization | 배상철 |
| 2012-03 | Use of a Multiethnic Approach to Identify Rheumatoid-Arthritis-Susceptibility Loci, 1p36 and 17q12 | 배상철 |
| 2019-07 | Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen | 배상철 |
| 2013-07 | Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities | 배상철 |
| 2012-11 | Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries | 배상철 |
| 2018-09 | Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization | 배상철 |
| 2016-09 | Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis | 배상철 |
| 2016-04 | Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis A meta-analysis | 배상철 |
| 2018-06 | Vitamin D receptor FokI, TaqI, and ApaI polymorphisms and susceptibility to systemic lupus erythematosus: an updated meta-analysis | 배상철 |
| 2017-01 | What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis? | 배상철 |
| 2014-04 | 류마티스관절염에서 DAS28에 근거한 보험급여기준 적용시 항 TNF제제 대상 환자 예측 | 배상철 |
| 2011-11 | 면역억제 치료를 받는 루푸스신염 환자에서 발생한 일차성 인플루엔자 폐렴 1예 | 배상철 |
| 2018-06 | 비스테로이드소염제의 안전한 사용 전략 | 배상철 |
| 2011-11 | 한국인 류마티스관절염 환자에서 항 TNF 제제의 지속성에 관한 연구 | 배상철 |
| 2015-08 | 항 Tumor Necrosis Factor 제제 사용 전 잠복결핵 진단전략에 따른 결핵 발생률 | 배상철 |
